Aura Biosciences AURA
NASDAQ AURA
$7.49 +0.12 (+1.63%)
As of: Sep 4, 2026 · 2:28 PM EDT

Aura Biosciences (AURA) Other Operating Expenses (2021 - 2022)

Aura Biosciences' (AURA) quarterly Other Operating Expenses came in at -$313000.0 in Q3 2022, down 6160.0% on a QoQ basis from -$5000.0 in Q1 2022.

Analysis

Aura Biosciences (AURA) Other Operating Expenses (2021 - 2022) Analysis & Trends

Aura Biosciences (AURA) has 2 years of Other Operating Expenses data on file, last reported at -$313000.0 in Q3 2022.

  • Quarterly Other Operating Expenses changed N/A year-over-year to -$313000.0 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was -$313000.0 (down 6160.0% YoY) and the FY2023 annual result came in at $208000.0, up 165.41% from the prior year.
  • Other Operating Expenses slipped to -$313000.0 in Q3 2022, from -$5000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of -$3000.0 in Q1 2021 to a low of -$313000.0 in Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Aura Biosciences 711.48 Mn 643.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -313,000.00
Mar 31, 2022 -5,000.00
Mar 31, 2021 -3,000.00